Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 2 of 2 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GABAPENTINA | [1] Gabapentin Gabapentin (Gabapentina) | [1] Gabapentin
Gabapentin
💬1. GABAPENTINA
| [5] CACNA2D1 CACNA2D1,CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 1. GABAPENTINA
| [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac ... | [1] 6 6 💬1. GABAPENTINA
| ||||||||||||||||||||
| 2 | GABAPENTINA KERN PHARMA | [1] Gabapentin Gabapentin (Gabapentina) | [1] Gabapentin
Gabapentin
💬2. GABAPENTINA KERN PHARMA
| [5] CACNA2D1 CACNA2D1,CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 2. GABAPENTINA KERN PHARMA
| [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac ... | [1] 6 6 💬2. GABAPENTINA KERN PHARMA
|